Clinical trial
A Study to Evaluate the Efficacy and Safety of Zenapax in Combination With…
NCT00048165 · Hoffmann-La Roche, Industry · Completed
Key facts
| NCT number | NCT00048165 |
|---|---|
| Title | A Study to Evaluate the Efficacy and Safety of Zenapax in Combination With CellCept, Cyclosporine, and Corticosteroids in Patients Undergoing Cardiac Transplantation |
| Official title | A Double-Blind, Placebo -Controlled, Randomized Study to Assess the Efficacy and Safety of Zenapax in Combination With CellCept, Cyclosporine, and Corticosteroids in Patients Undergoing Cardiac Transplantation. |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Heart Transplantation |
| Intervention type | Drug |
| Interventions | Daclizumab, Methylprednisolone, Mycophenolate mofetil, Placebo, cyclosporine |
| Enrollment | 434 |
| Start date | Aug 1, 1999 |
| Primary completion | Aug 1, 2002 |
| Completion | Aug 1, 2002 |
| First posted | Oct 25, 2002 |
| Last update posted | Jun 13, 2016 |
| Countries | Canada, Germany, Sweden, United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: